2017
DOI: 10.1111/bcp.13289
|View full text |Cite
|
Sign up to set email alerts
|

Dose sparing and the lack of a dose–response relationship with an influenza vaccine in adult and elderly patients – a randomized, double‐blind clinical trial

Abstract: Our data suggested that significant dose sparing is possible with the use of whole-virion vaccines and aluminium adjuvants, without compromising safety. This could have significant economic and public health impacts.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0
5

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 21 publications
(25 reference statements)
0
6
0
5
Order By: Relevance
“…When alum was included as an adjuvant, equivalent responses were seen when doses of influenza antigen were reduced from 15μg to 6μg in both young and elderly adults 30 . In a phase I study investigating the unlicensed adjuvant Advax (a polysaccharide particulate adjuvant derived from inulin) responses were equivalent between the adjuvant group that used a third of the antigen (15μg) and the unadjuvanted group that received 45μg influenza antigen 31 .…”
Section: Dose Sparingmentioning
confidence: 99%
“…When alum was included as an adjuvant, equivalent responses were seen when doses of influenza antigen were reduced from 15μg to 6μg in both young and elderly adults 30 . In a phase I study investigating the unlicensed adjuvant Advax (a polysaccharide particulate adjuvant derived from inulin) responses were equivalent between the adjuvant group that used a third of the antigen (15μg) and the unadjuvanted group that received 45μg influenza antigen 31 .…”
Section: Dose Sparingmentioning
confidence: 99%
“…MedDRA-kód (4) 18 év alatti személyek 18 év feletti személyek Összesen P-érték (7) SOC (5) /PT (6) Vizsgálat (1) Klinikai vizsgálat 1 (2) Vizsgálat (1) Klinikai vizsgálat 2 (3) Vizsgálat (1) Klinikai vizsgálat 1-2 (2,3) 226 120 361 601 587 721 n. a.…”
Section: Táblázatunclassified
“…A legutóbbi pandémia során munkacsoportunk sikeresen kifejlesztett egy csökkentett, 6 µg dózisú monovalens pándémiás oltóanyagot, ami a kisebb hemagglutinintartalom mellett is kellő immunogenitással rendelkezett, lehetővé téve ezzel a gyártókapacitás növelését [5]. Ezután a csökkentett, 6 µg hemagglutinintartalmú, trivalens szezonális vakcina (FluArt) fejlesztése és engedé-lyeztetése is sikerrel járt [6,7].…”
unclassified
See 2 more Smart Citations